| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327669 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
These results demonstrate the feasibility and safety of RFA for metastatic ovarian lesions to the liver in patients previously deemed as poor or non-surgical candidates, and suggest the potential for improvement in survival over unresected patients or in patients resected with residual disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Rod Mateo, Gagandeep Singh, Nicolas Jabbour, Suzanne Palmer, Yuri Genyk, Lynda Roman,